Hypha Discovery is a microbial technology company helping partners in pharmaceutical and agrochemical R&D succeed through the discovery and production of microbial and mammalian metabolites. We are experts in the scalable production of DMPK metabolites and generation of polar analogues, and are also a leading provider of unique natural product screening libraries and associated services.
NEWS & EVENTS
5th December, Oxford University, UK
Meet us at our exhibit in Oxford to learn how Hypha’s biocatalysis system can be applied for late stage functionalization. Our platform allows production and scale up of compound derivatives for SAR studies, improved solubility and bioavailability, and also creates handles for further derivatization at aliphatic and aromatic positions.
Our new brochure on drug metabolites and C-H activated derivatives is now available. Inside we feature interesting case studies and client projects, including the following topics:
- Phase l CYP and non-CYP metabolites
- Phase ll conjugated metabolites
- Isotopically labelled metabolites
- Lead diversification and late stage functionalization
- Polar / C-H activated derivatives